Spots Global Cancer Trial Database for pemetrexed (altima)
Every month we try and update this database with for pemetrexed (altima) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment | NCT00807573 | Lung Cancer | Paclitaxel Pemetrexed Bevacizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) | NCT01443078 | Lung Cancer | pemetrexed cisplatin Carboplatin Gemcitabine Hyd... Vinorelbine Tar... Docetaxel | 18 Years - | Memorial Sloan Kettering Cancer Center |